Wyatt CM, Le Meur Y. REPRISE: tolvaptan in advanced polycystic kidney disease. Kidney Int. 2018;93:292–295
Publication
, Journal Article
Published in: Kidney International
April 2018
Duke Scholars
Published In
Kidney International
DOI
ISSN
0085-2538
Publication Date
April 2018
Volume
93
Issue
4
Start / End Page
1019 / 1019
Publisher
Elsevier BV
Related Subject Headings
- Urology & Nephrology
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wyatt CM, Le Meur Y. REPRISE: tolvaptan in advanced polycystic kidney disease. Kidney Int. 2018;93:292–295. (2018). Kidney International, 93(4), 1019–1019. https://doi.org/10.1016/j.kint.2018.02.001
“Wyatt CM, Le Meur Y. REPRISE: tolvaptan in advanced polycystic kidney disease. Kidney Int. 2018;93:292–295.” Kidney International 93, no. 4 (April 2018): 1019–1019. https://doi.org/10.1016/j.kint.2018.02.001.
Wyatt CM, Le Meur Y. REPRISE: tolvaptan in advanced polycystic kidney disease. Kidney Int. 2018;93:292–295. Kidney International. 2018 Apr;93(4):1019–1019.
“Wyatt CM, Le Meur Y. REPRISE: tolvaptan in advanced polycystic kidney disease. Kidney Int. 2018;93:292–295.” Kidney International, vol. 93, no. 4, Elsevier BV, Apr. 2018, pp. 1019–1019. Crossref, doi:10.1016/j.kint.2018.02.001.
Wyatt CM, Le Meur Y. REPRISE: tolvaptan in advanced polycystic kidney disease. Kidney Int. 2018;93:292–295. Kidney International. Elsevier BV; 2018 Apr;93(4):1019–1019.
Published In
Kidney International
DOI
ISSN
0085-2538
Publication Date
April 2018
Volume
93
Issue
4
Start / End Page
1019 / 1019
Publisher
Elsevier BV
Related Subject Headings
- Urology & Nephrology
- 3202 Clinical sciences
- 1103 Clinical Sciences